Jaguar Health Inc (JAGX)
1.04
-0.02
(-1.89%)
USD |
NASDAQ |
Nov 04, 16:00
1.04
0.00 (0.00%)
After-Hours: 20:00
Jaguar Health Total Assets (Quarterly): 61.46M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 61.46M |
| March 31, 2024 | 55.39M |
| December 31, 2023 | 50.76M |
| September 30, 2023 | 45.38M |
| June 30, 2023 | 52.17M |
| March 31, 2023 | 56.93M |
| December 31, 2022 | 47.45M |
| September 30, 2022 | 51.29M |
| June 30, 2022 | 49.88M |
| March 31, 2022 | 52.91M |
| December 31, 2021 | 53.26M |
| September 30, 2021 | 59.26M |
| June 30, 2021 | 69.54M |
| March 31, 2021 | 68.71M |
| December 31, 2020 | 42.84M |
| September 30, 2020 | 36.23M |
| June 30, 2020 | 37.58M |
| March 31, 2020 | 33.28M |
| December 31, 2019 | 36.41M |
| September 30, 2019 | 35.63M |
| Date | Value |
|---|---|
| June 30, 2019 | 36.07M |
| March 31, 2019 | 40.66M |
| December 31, 2018 | 41.04M |
| September 30, 2018 | 46.12M |
| June 30, 2018 | 46.16M |
| March 31, 2018 | 50.27M |
| December 31, 2017 | 43.63M |
| September 30, 2017 | 59.99M |
| June 30, 2017 | 4.939M |
| March 31, 2017 | 3.574M |
| December 31, 2016 | 3.563M |
| September 30, 2016 | 5.102M |
| June 30, 2016 | 7.204M |
| March 31, 2016 | 11.98M |
| December 31, 2015 | 12.41M |
| September 30, 2015 | 16.64M |
| June 30, 2015 | 13.86M |
| March 31, 2015 | 4.844M |
| December 31, 2014 | 4.42M |
| June 30, 2014 | 6.217M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
33.28M
Minimum
Mar 2020
69.54M
Maximum
Jun 2021
50.56M
Average
51.29M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 385.92M |
| Alaunos Therapeutics Inc | 4.678M |
| Oragenics Inc | 2.710M |
| Cocrystal Pharma Inc | 21.57M |
| Chimerix Inc | 178.51M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 44.88M |
| Shareholders Equity (Quarterly) | 16.91M |
| Debt to Equity Ratio | 1.948 |
| Current Ratio | 2.096 |
| Net Debt Paydown Yield | 0.17% |